type="text/javascript">

US FDA approves Japanese Takeda drug for colitis and Crohn’s

Posted On 26 May 2014
By :

U.S. health regulators on Tuesday approved a drug from Japan’s Takeda Pharmaceutical Co Ltd to treat the chronic debilitating inflammatory diseases ulcerative colitis and Crohn’s disease. The Food and Drug Administration said it had approved vedolizumab, which will be sold under the brand name Entyvio, for patients who failed to gain adequate relief from one or more current standard treatments.

Read the source article at reuters.com

About the Author

Leave a Reply

*